223
Relmada Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
153
FY23:
97.5
FY24:
45.8
FY25:
94.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.03
FY22:
0.03
FY23:
0.04
FY24:
0.02
FY25:
0.02
Total assets
Change from FY21 to FY25
millions USD
FY21:
223
FY22:
153
FY23:
97.6
FY24:
45.8
FY25:
94.0
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
15.1
FY22:
12.5
FY23:
12.2
FY24:
10.3
FY25:
6.43
(negative)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
0.00
FY25:
1.06
(positive)
Change from FY21 to FY25
millions USD
FY21:
208
FY22:
140
FY23:
85.4
FY24:
35.5
FY25:
86.5
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
223
FY22:
153
FY23:
97.6
FY24:
45.8
FY25:
94.0
All amounts in millions USD